Araújo Soraia G, Vale Martinha M, Araújo Inês M, Azevedo Raquel, Oliveira Ana
Critical Care Medicine, Hospital de Braga, Braga, PRT.
Internal Medicine, Hospital de Braga, Braga, PRT.
Cureus. 2024 Oct 18;16(10):e71757. doi: 10.7759/cureus.71757. eCollection 2024 Oct.
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of uncommon and frequently severe lymphomas. There are around 30 different subtypes, with peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) and angioimmunoblastic T-cell lymphoma having the poorest outcomes under standard chemotherapy. We discuss two cases with unusual initial presentations of these aggressive subtypes of peripheral T-cell lymphoma. The first case is a peripheral T-cell lymphoma, not otherwise specified, which initially presents with pain in the left hip. For six months, this pain was erroneously labeled as degenerative osteoarticular pathology. When exploring further the patient's symptoms, one can see a set of constitutional symptoms that accompany the pain and end up sounding alarm bells. Imaging examinations reveal a lytic bone lesion in the iliac crest and multiple adenopathy formations. The bone lesion biopsy provides a definitive diagnosis, and after six cycles of chemotherapy, the control examinations reveal a complete remission. The second case is a nodal T-follicular helper lymphoma, angioimmunoblastic subtype, that initially appeared to be a respiratory infection that did not respond to antibiotic therapy. However, by carefully reviewing the anamnesis, it was possible to identify constitutional symptoms that should have alerted to a different diagnosis. Imaging examinations confirmed the suspicion and reported numerous adenopathies as well as splenomegaly associated with splenic infarction. Axillary adenopathy biopsy dictated the diagnosis. The patient completed six cycles of chemotherapy with a complete response. These cases demonstrate how crucial it is to keep an elevated level of suspicion for this uncommon pathology to avoid delays in diagnosis and thereby maximize the chance of a successful outcome.
外周T细胞淋巴瘤(PTCL)是一组异质性的罕见且通常较为严重的淋巴瘤。大约有30种不同的亚型,其中外周T细胞淋巴瘤,非特指型(PTCL-NOS)和血管免疫母细胞性T细胞淋巴瘤在标准化疗下预后最差。我们讨论两例具有外周T细胞淋巴瘤这些侵袭性亚型不寻常初始表现的病例。第一例是外周T细胞淋巴瘤,非特指型,最初表现为左髋部疼痛。六个月来,这种疼痛被错误地诊断为退行性骨关节病变。在进一步探究患者症状时,可以发现一系列伴随疼痛的全身症状,最终敲响了警钟。影像学检查显示髂嵴有溶骨性骨病变和多处淋巴结肿大。骨病变活检给出了明确诊断,经过六个周期的化疗后,对照检查显示完全缓解。第二例是结内T滤泡辅助性淋巴瘤,血管免疫母细胞亚型,最初似乎是对抗生素治疗无反应的呼吸道感染。然而,通过仔细回顾病史,有可能识别出本应提示不同诊断的全身症状。影像学检查证实了怀疑,并报告有多处淋巴结肿大以及与脾梗死相关的脾肿大。腋窝淋巴结活检确定了诊断。患者完成了六个周期的化疗,获得完全缓解。这些病例表明,对于这种罕见疾病保持高度怀疑是多么关键,以避免诊断延误,从而最大限度地提高成功治疗的机会。